The dPCR & qPCR market size is expected to reach US$ 18.23 billion by 2030 from US$ 8.97 billion in 2022; it is anticipated to record a CAGR of 9.3% during the forecast period. To explore the ...
After a lifetime on the frontiers of the fight against HIV, Linda-Gail Bekker could finally see the end of the epidemic in sight. For decades, HIV experts had dreamed of an elusive vaccine to ...
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda. A multi-national ...
Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and tuberculosis. With no family to care for him, Evans was referred to the ...
JOHANNESBURG, Feb 18 (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order ...
HIV medications stop the virus from making copies of itself. The Food and Drug Administration (FDA) has approved more than 50 HIV medications. HIV is transmitted through contact with blood, semen ...
In a study of nearly 600 people, published in Science on 20 February 1, the tool identified whether participants were healthy or had COVID-19, type 1 diabetes, HIV or the autoimmune disease lupus ...
The data, presented in an oral session at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025, in San Francisco, shows that IMC-M113V – the first T cell receptor bispecific therapy ...
HIV infections (human immunodeficiency virus infections) include the spectrum of infections caused by the virus HIV that range from asymptomatic seropositivity to acquired immunodeficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback